Medical therapy for Crohn's disease

Stephen B. Hanauer, Themistocles Dassopoulos

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

While the etiopathogenesis of Crohn's disease (CD) remains enigmatic, progress in basic and cUnical research, and the successful application of specific therapies in clinical trials, have led to the formulation of evidence-based therapeutic guidelines. However, there remain significant gaps in the evidence base that preclude complete reliance on controlled trials to define guidelines. Nevertheless, therapeutic algorithms for CD have been defined that sequence therapy from induction of clinical remission followed by maintenance therapy to prevent relapse. Two corollaries to maintenance therapy include the treatment of steroid dependence and prevention of postoperative recurrence. This chapter will review the therapeutic agents used to treat CD according to the phase of therapy (induction or maintenance), with emphasis on each agent's position according to disease severity (mild to moderate, severe, or fulminant) and extent (location in small and/or large intestine).

Original languageEnglish (US)
Title of host publicationInflammatory Bowel Disease
Subtitle of host publicationFrom Bench to Bedside
PublisherSpringer US
Pages659-680
Number of pages22
ISBN (Print)0387258078, 9788847004337
DOIs
StatePublished - Dec 1 2006

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Medical therapy for Crohn's disease'. Together they form a unique fingerprint.

Cite this